Upregulation of TNF-α and IL-3 expression in lesional and uninvolved skin in different types of urticaria

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 2 II, 1999, Pages 307-314

  Hermes, Barbara ^a   Prochazka, Arm Karin ^a   Haas, Norbert ^b   Jurgovsky, Klaus ^c   Sticherling, Michael ^a   Henz, Beate M ^a,d  

^a VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytokines; Endothelial cells; IL 3; IL 8; Keratinocytes; Mast cells; TNF; Urticaria

Indexed keywords

INTERLEUKIN 3; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; HUMAN; IMMUNOPATHOGENESIS; MAST CELL; PRICK TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN INFLAMMATION; URTICARIA;

CYTOKINES; ENDOTHELIUM; HUMANS; INTERLEUKIN-3; MAST CELLS; SKIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; URTICARIA;

EID: 0033047984     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70506-3     Document Type: Article

References (48)

1. Henz BM, Zuberbier T, Grabbe J, Monroe E. Urticaria - clinical, diagnostic and therapeutic aspects. Berlin: Springer; 1997.
2. Bressler RB. Pathophysiology of chronic urticaria. Immunol Allergy Clin North Am 1995;15:659-77.
3. Möller A, Henz BM, Grützkau A, Lippert U, Schwarz T, Aragane Y, et al. Comparative cytokine gene expression, regulation and release by human mast cells. Immunology 1998;93:289-95.
4. Lawlor F, Bird C, Camp RDR, Barlow R, Barr RM, Kobza-Black A, et al. Increased interleukin 6, but reduced interleukin 1, in delayed pressure urticaria. Br J Dermatol 1993;128:500-3.
5. Czarnetzki BM, Zwadlo-Klarwasser G, Bröcker E-B, Sorg C. Immunohistochemical demonstration of migration inhibitory factor (MIF) in different types of urticaria. J Invest Dermatol 1989;93:471-4.
6. Kano Y, Orihara M, Shiohara T. Cellular and molecular dynamics in exercise-induced urticarial vasculitis lesions. Arch Dermatol 1998;134:62-7.
7. Toppe E, Haas N, Henz BM. Neutrophilic urticaria - clinical features, histological changes and possible mechanisms. Br J Dermatol 1998;138:248-53.
8. Kay AB, Ying S, Varney VA, Gaga M, Durham SR, Moqbel R, et al. Messenger RNA expression of the cytokine gene cluster, interleukin-3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-8.
9. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
10. Horsmanheimo L, Harvima IT, Jarvikallio A, Havima RJ, Naukkarinen A, Horsmanheimo M. Mast cells as a major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994;131:348-53.
11. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995;155:297-307.
12. Bradding P, Feather ICH, Wilson S, Bardin PG, Heusser CH, Holgate ST et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitis subjects: the mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993;151:3853-65.
13. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
14. Luger TA, Beissert S, Schwarz T. The epidermal cytokine network. In: Bos JD, editor. Skin Immune System (SIS). 2nd ed. Boca Raton: CRC Press; 1997. p. 271-310.
15. Van-Overveld FJ, Jorens PG, Rampart M, de Backer W, Vermeire PA. Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin Exp Allergy 1991;21:711-4.
16. Walsh A, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor-α which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:4220-4.
17. Wershil BK, Wang Z-S, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase reaction in the mouse is mast cell dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor α. J Clin Invest 1991;87:446-53.
18. Schröder J-M, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 1987;139:3474-83.
19. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988;167:1547-59.
20. Lippert U, Artuc M, Grützkau A, Möller A, Kenderessy-Szabo A, Schadendorf D, et al. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol 1998;161:2600-8.
21. Warringa RA, Mengelers HJ, Raaijmakers JA, Bruijnzeel PL, Koenderman L. Upregulation of formyl-peptide and interleukin- 8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993;91:1198-205.
22. Erger RA, Casale TB. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol 1995;268:L117-22.
23. Douglass J, Dhami D, Bulpitt M, Lindley IL, Shute J, Church MK, et al. Intradermal challenge with interleukin-8 causes tissue oedema and neutrophil accumulation in atopic and nonatopic human subjects. Clin Exp Allergy 1996;26:1371-9.
24. Möller A, Lippert U, Leßmann D, Kolde G, Hamann K, Welker P, et al. Human mast cells produce IL-8. J Immunol 1993;151:3261-6.
25. Park HS, Jung KS, Shute J, Holgate ST, Djukanovic R. Allergen-induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival. Eur Respir J 1997;10:1476-82.
26. Schrader JW. The panspecific hemopoietin of activated T lymphocytes (interleukin 3). Ann Rev Immunol 1986;4:205-30.
27. Kita H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human eosinophils and neutrophils. J Exp Med 1991;174:745-8.
28. Haas N, Iwen W, Hamann K, Grabbe J, Figdor C, Czarnetzki BM. β2-Integrins in different forms of urticaria. Br J Dermatol 1995;133:48-53.
29. Miyamasu M, Misaki Y, Izumi S, Takaishi T, Matsushima K, Morita Y, et al. Eosinophilopoietic factors prime eosinophils for increased interleukin-8 generation. Allergy 1997;52:317-22.
30. Yousefi S, Blaser K, Simon HU. Activation of signaling pathways and prevention of apoptosis by cytokines in eosinophils. Int Arch Allergy Immunol 1997;112:9-12.
31. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. Am J Respir Cell Mol Biol 1997;16:455-65.
32. Khew-Goodall Y, Butcher CM, Litwin MS, Newlands S, Korpelainen EI, Noack LM. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood 1996;87:1432-8.
33. Zuberbier T, Schadendorf D, Haas N, Hartmann K, Henz BM. Enhanced P-selectin expression in chronic and dermographic urticaria. Int Arch Allergy Clin Immunol 1997;114:86-9.
34. Schadendorf D, Tiedemann K-H, Haas N, Czarnetzki BM. Detection of human papillomaviruses in paraffin-embedded condylomata acuminata. Comparison of immunohistochemistry, in situ hybridization and polymerase chain reaction. J Invest Dermatol 1991;97:549-54.
35. Sticherling M, Bornscheuer E, Schröder J-M, Christophers E. Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol 1991;96:1-5.
36. Haas N, Toppe E, Henz BM. Microscopic morphology in different types of urticaria. Arch Dermatol 1998;134:41-6.
37. Haas N, Schadendorf D, Henz BM. Endothelial adhesion molecules in immediate and delayed urticarial whealing reactions. Int Arch Allergy Immunol 1998;115:210-4.
38. Haas N, Iwen W, Grabbe J, Uchanska-Ziegler B, Czarnetzki BM. MHC class II expression in different forms of urticaria. Int Arch Allergy Immunol 1996;109:177-82.
39. Barlow RJ, Ross EL, MacDonald D, Kobza Black A, Greaves MW. Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria. Br J Dermatol 1994;131:341-7.
40. Gaboury JP, Johnston B, Niu X-F, Kubes PJ. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J Immunol 1995;154:804-13.
41. Thorlacius H, Raud J, Rosengren-Beezley S, Forrest MJ, Hedqvist P, Lindborn L. Mast cell activation induces P-selectin-dependent leukocyte rolling and adhesion in postcapillary venules in vivo. Biochem Biophys Res Commun 1994;203:1043-9.
42. MacLeod JDA, Anderson DF, Baddeley SM, Holgate ST, McGill JI, Roche WR. Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva. Clin Exp Allergy 1997;27:1328-34.
43. TC) in cutaneous inflammation using novel enzyme-histochemical staining techniques. Exp Dermatol 1994;3:290-7.
44. Bécherel P-A, Chosidow O, LeGoff L, Francès C, Debre P, Mossalayi MD, et al. Inducible nitric oxide synthase and pro inflammatory cytokine expression by human keratinocytes during acute urticaria. Mol Med 1997;3:686-94.
45. Bécherel P-A, LeGoff L, Francès C, Chosidow O, Guillosson J-P, et al. Cutting edge. Induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3',5'-monophosphate-dependent mechanism. J Immunol 1997;159:5761-5.
46. Kaplan AP, Horokava Z, Katz SI. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 1978;61:350-4.
47. Haas N, Motel K, Czarnetzki BM. Comparative immunoreactivity of the eosinophil constituents MBP and ECP in different types of urticaria. Arch Dermatol Res 1995;287:180-5.
48. Schröder JM. Inflammatory mediators and chemoattractants. Clin Dermatol 1995;13:137-50.